SOURCE: ScripsAmerica


September 16, 2014 08:00 ET

ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement

TYSONS CORNER, VA--(Marketwired - Sep 16, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has entered into a prescription sourcing agreement with Ohio-based Jungle Jim's International Market, which has pharmacy licenses in several states.

The Company will obtain prescriptions to be filled by "Jungle Jim's" within its areas of drug delivery licensure and receive a percentage of the revenue generated by each prescription upon its reimbursement by insurance providers. With this agreement, ScripsAmerica has expanded its specialty pharmacy operations by gaining access to have prescription drugs distributed in 12 new US states.

ScripsAmerica's CEO, Bob Schneiderman, commented, "Scrips' new sourcing agreement marks the rapid growth of our specialty pharmacy operations which have experienced great success and revenue growth in 2014. Jungle Jim's is a unique, supersized international market whose pharmacy processes a number of prescriptions across several states which will not only increase ScripsAmerica's overall specialty pharmacy revenue base but also our geographic scope by providing access to process prescriptions in many new states across the country."

About Jungle Jim's International Market

Jungle Jim's International Market is a large supermarket in Fairfield, Ohio with a satellite location near Cincinnati. The main location has been described as a theme park of food that offers 180,000 items with over 300,000 square feet of floor space. Jungle Jim's is notable for having one of the largest wine collections in the United States as well as live seafood tanks and an in-store cooking school. Each week, the store is visited by approximately 82,000 shoppers, many of which drive from other cities to access the store's large, international variety of foods. To learn more, visit

About ScripsAmerica, Inc.

ScripsAmerica is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information